Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease.
Bohm M, Xu R, Zhang Y, Varma S, Fischer M, Kochhar G, Boland B, Singh S, Hirten R, Ungaro R, Shmidt E, Lasch K, Jairaith V, Hudesman D, Chang S, Lukin D, Swaminath A, Sands BE, Colombel JF, Kane S, Loftus EV Jr, Shen B, Siegel CA, Sandborn WJ, Dulai PS; VICTORY Collaboration.
Bohm M, et al.
Aliment Pharmacol Ther. 2020 Aug;52(4):669-681. doi: 10.1111/apt.15921. Epub 2020 Jul 13.
Aliment Pharmacol Ther. 2020.
PMID: 32656800
Free PMC article.